Background illustration for clinical trials search

Paid Clinical Trials Glendale

Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

for
Atopic Dermatitis
Location: Northridge CA, San Diego CA, Dallas TX, Fargo ND,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT07765888

Phase 3, Recruiting

FT839 in Autoimmune Diseases

for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07800871

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Beverly Hills CA, Los Angeles CA, Los Alamitos CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase 3, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase 1, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Beverly Hills CA, Koreatown CA, Los Angeles CA,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

for
Folliculotropic Mycosis Fungoides,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04930653

Phase 2, Recruiting

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

for
Relapsed Acute Myeloid Leukemia (AML),
Location: Duarte CA, Houston TX, Nashville TN, Columbus OH,
Sponsor: Auron Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06846606

Phase 1, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA, Los Angeles CA, Orange CA, Irvine CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA, Irvine CA, Palo Alto CA, Goodyear AZ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase 2, Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Santa Monica CA, Phoenix AZ, San Antonio TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Beverly Hills CA, San Antonio TX, Margate FL
Sponsor: Pyrotech Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06244992

Phase 1, Phase 2, Recruiting

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Bakersfield CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06345729

Phase 3, Recruiting

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Location: Gardena CA, Long Beach CA, Fountain Valley CA,
Sponsor: Altimmune, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07795164

Phase 3, Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for
Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer,
Location: Beverly Hills CA, Santa Monica CA, Houston TX
Sponsor: Epkin

Sex: All

Age: 18+

Code: NCT06789172

Phase 1, Recruiting

Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care

for
Breast Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT07690852

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Los Alamitos CA, Anaheim CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

for
Carcinoma, Non-Small-Cell Lung Cancer,
Location: Beverly Hills CA, Tyler TX, Pittsburgh PA, Norfolk VA
Sponsor: Kiromic BioPharma Inc.

Sex: All

Age: 18+

Code: NCT06069570

Phase 1, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Beverly Hills CA, Los Angeles CA, Orange CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

Shoulder Strength in Baseball Players

for
Healthy Subjects
Location: Loma Linda CA
Sponsor: Loma Linda University

Sex: All

Age: 15 - 22

Code: NCT07209423

Recruiting

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Los Angeles CA, Fountain Valley CA, Portland OR, Surrey,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07783542

Phase 2, Recruiting